These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5780235)

  • 1. [Serum complement activity. Clinical and humoral correlations].
    Purice S; Ghelerter L; Drăgoi T; Lungu N
    Med Interna (Bucur); 1969 Feb; 21(2):173-80. PubMed ID: 5780235
    [No Abstract]   [Full Text] [Related]  

  • 2. [Physical criteria of pathological processes. III. Structure of the correlation between the level of steady brain potential with serum complement proteins in rheumatic diseases].
    Klimenko LL; Kozlov LV; Kudriashova LP; Protasova OV; Maksimova IA; Komarova MN; Konradov AA; Turna AA; Soiustova EL; Matveev GN
    Biofizika; 1999; 44(1):128-31. PubMed ID: 10330589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Titers of C 3 factor of serum complement in various autoimmune diseases].
    Lehman C; Andreis M; Bennett L; Godoy G
    Rev Med Chil; 1972; 100(5):497-501. PubMed ID: 4625016
    [No Abstract]   [Full Text] [Related]  

  • 4. Topics in clinical medicine. Complement levels in disease.
    Townes AS
    Johns Hopkins Med J; 1967 May; 120(5):337-43. PubMed ID: 6024563
    [No Abstract]   [Full Text] [Related]  

  • 5. [Behavior of complement in serum and synovial fluid in rheumatic diseases].
    Gangl A; Thumb N
    Wien Z Inn Med; 1968; 49(7):251-7. PubMed ID: 5737587
    [No Abstract]   [Full Text] [Related]  

  • 6. [The level of serum thymic activity in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Ternovoĭ KS; Selezneva TN; Gandzha IM; Babynina LIa; Skorik AIu; Ermekova VM
    Ter Arkh; 1993; 65(8):66-7. PubMed ID: 8211807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the third component of complement in synovial fluid from arthritic patients.
    Lundh B; Hedberg H; Laurell AB
    Clin Exp Immunol; 1970 Mar; 6(3):407-11. PubMed ID: 5442523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenesis of complement decrease in the synovial fluid in rheumatoid arthritis and disseminated lupus erythematosus].
    Peltier AP; de Sèze S
    Rev Rhum Mal Osteoartic; 1971 Jan; 38(1):61-8. PubMed ID: 5549169
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical importance of investigations of completed and incompleted phagocytosis and the level of serum complement as indicators of nonspecific immunological reactivity of patients with systemic lupus erythematosus].
    Ivanova AV; Selivanova IA; Poroshina NS; Gagarina LN
    Vopr Revm; 1973; 13(2):51-2. PubMed ID: 4772875
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum levels of C1q, C1r and C1s in normal and pathologic sera.
    De Bracco MM; Manni JA
    Arthritis Rheum; 1974; 17(2):121-8. PubMed ID: 4205506
    [No Abstract]   [Full Text] [Related]  

  • 11. Complement and complement components in diseases of possible auto-immunological pathogenesis.
    JONSEN J; KASS E
    Acta Rheumatol Scand; 1961; 7():21-6. PubMed ID: 13790639
    [No Abstract]   [Full Text] [Related]  

  • 12. [The significance of immunologic tests in the diagnosis and differential diagnosis of systemic lupus erythematosus and rheumatoid arthritis].
    Guceva B; Grlickov M; Marina N; Calovski J; Cakalaroska D; Pusevski A
    Reumatizam; 1980; 27(1):1-4. PubMed ID: 6156480
    [No Abstract]   [Full Text] [Related]  

  • 13. [Significance of reduced complement level in the articular fluid. 81 cases].
    Del Pino Montes J; Meyer O; Borda Iriarte O; Belenguer Prieto R; Peltier AP; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Jan; 50(1):19-21. PubMed ID: 6601817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibronectin and diseases in internal medicine].
    Backhaus M; Mielke F; Lukowsky A
    Z Arztl Fortbild (Jena); 1986; 80(21):883-7. PubMed ID: 3494345
    [No Abstract]   [Full Text] [Related]  

  • 15. [Complement and its components in selected autoimmune diseases].
    Pietruska Z
    Pol Tyg Lek; 1980 Jan; 35(1):27-30. PubMed ID: 6154287
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dynamics of the patient's proteinogram in rheumatoid arthritis and systemic lupus erythematosus as affected by hemosorption therapy].
    Dmitriev AA; Shevchenko OP; Petrunin DD
    Ter Arkh; 1984; 56(5):81-4. PubMed ID: 6463893
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum complement determinations in patients with quiescent systemic lupus erythematosus.
    Sullivan KE; Wisnieski JJ; Winkelstein JA; Louie J; Sachs E; Choi R; Veksler E; Goldman D; Petri M
    J Rheumatol; 1996 Dec; 23(12):2063-7. PubMed ID: 8970042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complement system in human pathology].
    Tedesco F
    Recenti Prog Med; 1971 Dec; 51(6):501-26. PubMed ID: 5172401
    [No Abstract]   [Full Text] [Related]  

  • 19. [Von Willebrand factor in plasma of patients with rheumatoid arthritis and lupus erythematosus].
    Paczuski R; Iwan-Zietek I; Kotschy M; Bielawska J; Sadkiewicz S
    Pol Merkur Lekarski; 1998 May; 4(23):254-6. PubMed ID: 9825655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The content of interleukin-1 beta in the blood serum of patients with systemic lupus erythematosus and rheumatoid arthritis].
    Ketlinskiĭ SA; Alekseeva TG; Perumov ND; Simbirtsev AS
    Ter Arkh; 1993; 65(12):51-4. PubMed ID: 8146772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.